Clinical Trial Update: Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial completion update for cabazitaxel combined with prednisone and neutropenia-prophylaxis in metastatic castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Jevtana (cabazitaxel)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Sanofi | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED